Morgan Stanley Enanta Pharmaceuticals Inc Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Morgan Stanley holds 2,045,145 shares of ENTA stock, worth $25.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,045,145
Previous 1,173,058
74.34%
Holding current value
$25.1 Million
Previous $11 Million
223.5%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
21.7MCall Options Held
9.4KPut Options Held
3.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$25.7 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$23.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.84MShares$22.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.24MShares$15.1 Million0.29% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.12MShares$13.8 Million8.71% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $254M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...